Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-4-28
pubmed:abstractText
Tamoxifen's cost-benefit ratio for breast ductal intraepithelial neoplasia (DIN) is unclear. Since low-dose tamoxifen showed a favorable modulation of breast cancer biomarkers in phase II trials, a monoinstitutional cohort of women with DIN treated with low-dose tamoxifen or no systemic treatment was analyzed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
949-54
pubmed:meshHeading
pubmed-meshheading:19858087-Adult, pubmed-meshheading:19858087-Aged, pubmed-meshheading:19858087-Aged, 80 and over, pubmed-meshheading:19858087-Antineoplastic Agents, Hormonal, pubmed-meshheading:19858087-Breast Neoplasms, pubmed-meshheading:19858087-Carcinoma, Ductal, Breast, pubmed-meshheading:19858087-Carcinoma in Situ, pubmed-meshheading:19858087-Cohort Studies, pubmed-meshheading:19858087-Dose-Response Relationship, Drug, pubmed-meshheading:19858087-Female, pubmed-meshheading:19858087-Follow-Up Studies, pubmed-meshheading:19858087-Humans, pubmed-meshheading:19858087-Middle Aged, pubmed-meshheading:19858087-Neoplasm Recurrence, Local, pubmed-meshheading:19858087-Postmenopause, pubmed-meshheading:19858087-Receptors, Estrogen, pubmed-meshheading:19858087-Receptors, Progesterone, pubmed-meshheading:19858087-Survival Rate, pubmed-meshheading:19858087-Tamoxifen, pubmed-meshheading:19858087-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study.
pubmed:affiliation
Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't